About this trial
Traumatic peripheral nerve injury is a common cause of chronic neuropathic pain, muscle weakness, and functional limitation, particularly in young and active individuals. Current conservative and pharmacological treatments often provide incomplete relief or carry side effects. High-intensity peripheral magnetic stimulation (PMS) is a non-invasive method that may help reduce neuropathic pain and support motor recovery, but evidence in traumatic nerve injury is limited.
This randomized, double-blind, sham-controlled trial aims to evaluate whether high-intensity PMS, added to a standardized therapeutic exercise program, improves pain, function, quality of life, and electrophysiological measures in adults with traumatic peripheral nerve injury. Participants will be randomly assigned to receive either active PMS or sham PMS, in addition to the same exercise program. Outcomes will be assessed at baseline, 4 weeks, and 8 weeks.
Eligibility criteria
Qualifiers
Age between 18 and 65 years
Traumatic peripheral nerve injury
Unilateral traumatic peripheral neuropathy confirmed by electromyography (EMG)
Nerve injury occurring at least 3 months prior
Disqualifiers
Active infection or malignancy
Metal implant or shrapnel in the application area
Electronic implants (e.g., cardiac pacemaker, spinal cord stimulator, deep brain stimulator)
Central nervous system diseases
Trial design
Treatments tested in this trial
- High-Intensity Peripheral Magnetic Stimulation
- Sham Peripheral Magnetic Stimulation
- Therapeutic Exercise Program